Though the mechanisms underlying GCN2-mediated regulation of AgRP neuron activity are unknown, we show here for the first time that GCN2 is involved in depression, and thus it might be a potential drug target to treat this condition. This evidence concerns the gene EIF2AK4 and major depressive disorder.